Notably, AGER and MST1 exhibited high frequency among the identified mediating networks, which may underscore potential involvements in the pathogenesis and offer promising therapeutic targets to mitigate CAD risk in individuals with obesity and unhealthy lifestyle factors. The gene discussed is MST1; the disease is obesity due to melanocortin 4 receptor deficiency.